您要查找的是不是:
- Gestational fasting glucose 妊娠血糖
- Lowering the cut-point for impaired fasting glucose, and why? 为什么要下调空腹血糖受损的下限切点?
- Bioaailable T was associated with HOMA-IR (P <0.001), but not fasting glucose. 生物可利用T与HOMA-IR相关(P<0.;001),但与空腹血糖无关。
- The changes and Significance of plasma insulin in patients with impaired fasting glucose or impaired glucose tolerance. 空腹血糖异常、糖耐量减低患者血清胰岛素水平的变化及其意义。
- High fasting glucose was associated with risk for pancreatic, endometrium and urinary tract cancers. 空腹高血糖与胰腺癌,子宫内膜癌和尿道癌的风险有关。
- No association was observed between impaired fasting glucose or undiagnosed type 2 diabetes and depressive symptoms. 空腹血糖受损或未确诊的2型糖尿病患者与抑郁症状之间未发现存在联系。
- No association was obsered between impaired fasting glucose or undiagnosed type 2 diabetes and depressie symptoms. 空腹血糖受损或未确诊的2型糖尿病患者与抑郁症状之间未发现存在联系。
- Objective:To Investigate morbidity of carotid arterioles atherosclerosis in diabetes mellitus and impaired fasting glucose patients. 目的:探讨糖尿病、糖代谢异常患者颈动脉粥样硬化的情况。
- All subjects were evaluated BMI, waist-to-hip ratio, fasting glucose level, glycosylated hemoglobin and D-dimer level in plasma. 所有受试者均进行体重指数、腰臀围比、空腹血糖、糖化血红蛋白、血脂以及血浆D-二聚体的检测,进行统计学分析。
- Main Outcome Measures: Impaired fasting glucose (IFG) and diabetes were defined based on fasting blood sugar and/or treatment for diabetes. 主要结果评价:空腹血糖受损(IFG)及糖尿病,根据空腹血糖和/或进行糖尿病治疗来确定。
- But in the long term, particularly if you have a genetic predisposition, impaired fasting glucose and glucose intolerance may become manifest. 但是从长远来看,尤其是如果你具有遗传易感性,则空腹血糖受损或糖耐量受损将很明显。
- When the Swedish study started, the men took fasting glucose tests to show how well their body used insulin, a hormone that controls blood sugar. 在这个瑞典的研究开始过程时,人们用快速血糖试验来检测机体利用胰岛素的程度,胰岛素是调节血糖的一种激素。
- Fasting insulin levels and AUC of the three groups decreased significantly (P<0.05), but the fasting glucose level and AUC remained unchanged after 24 weeks of exercise. 24周耐力训练后;三种基因型受试者的空腹胰岛素水平和曲线下面积(AUC)均显著下降(P<0.;05);但训练并未引起空腹血糖及其AUC显著变化。
- The participants had a typical fasting glucose of 7.6 mmol/L before the start of the study. (Fasting glucose levels among non-diabetics are generally 5.5 mmol/L or lower. 试验前,连续三天早上7点测空腹血糖。然后,用标准化的计划饮食两天,睡前两勺苹果酒醋或水加1盎司的干酪。在3到5天的”冲刷期“后,”冲刷期“内不饮醋,患者就进入选定的治疗。
- The changes of body mass index(BMI),fasting glucose(FPG),fasting insulin(FINS),insulin resistance(HOMA-IR),2 h PG,2 h INS,total cholesterol(TC) and triglyceride(TG),before and after treatment were determined,and the findings were compared and analyzed. 观察二组治疗前和治疗6个月后体质量指数(BMI)、胰岛素抵抗指数(HOMA-IR)、空腹血糖(FPG)和空腹胰岛素(FINS)、餐后2 h血糖和胰岛素(2 h PG和INS),及血浆总胆固醇(TC)和三酰甘油(TG)的变化,观察治疗组治疗期间不良反应。
- In 631 subjects whose FPG levels were more than 6.1mmol/L and less than 7.0mmol/L,348 patients(55%)were diagnosed as diabetes mellitus by 2hPG,213 ones(34%)as impaired glucose tolerance(IGT),70 subjects(11%)as impaired fasting glucose(IFG). 6 31例FPG大于或等于 6 1mmol/L ,且小于 7 0mmol/L ,以 2hPG标准判断达糖尿病标准者 34 8例 (5 5%25) ,糖耐量减低 (IGT) 2 13例 (34%25) ,空腹高血糖 (IFG) 70例 (11%25)。
- A total of 50 subjects were diagnosed with diabetes(DM),58 subjects with impaired glucose tolerance(IGT) and/or impaired fasting glucose(IFG) (impared glucose regulation,IGR),141 subjects with normal glucose tolerance and HbA 1c(NGT). 总共50例新诊断糖尿病(DM),58例被诊断为空腹血糖受损(IFG)和(或)糖耐量减低(IGT),统称糖调节受损(IGR),141 例OGTT和HbA1c均正常(NGT);
- Methods Determination of CRP levels in normoglycemic participants and participants who had diabetes, impuired fasting glucose (IFG) or impaired gluase tolerance (IGT) was made by ELISA. 方法用ELISA方法测定成人中糖尿病患者、空腹高血糖(IFG)者、糖耐量减低(IGT)者及血糖正常者的CRP水平。
- Methods:Serum contents of leptin,LH/FSH and fasting insulin,and plasma level of fasting glucose were detected by radioimmunoassay and oxidase test respectively in 17 patients with PCOS and 20 controls. 方法 :采用放射免疫法检测 17例PCOS和 2 0例对照组血清leptin、促黄体生成素 (LH) /促卵泡素 (FSH)及空腹胰岛素水平 ,用氧化酶法检测血浆葡萄糖浓度。
- Group OB included subjects of normal glucose tole rance(group NGT, n =68),impaired glucose tolerance/impaired fasting glucose(group IGT, n =46),diabetes(group DM, n =38)and simple obese(group SOB, n =32). OB组包括糖耐量正常者 68例(NGT组 ) ,糖耐量异常 /空腹血糖受损者 46例 (IGT组 )和糖尿病 38例 (DM组 )以及单纯性肥胖者 32例 (SOB组 )。